Innovation Ulster
VC Fund
Newtownabbey, United Kingdom
Innovation Ulster is a VC fund in Newtownabbey focused on Health Care and Biotechnology. Innovation Ulster Limited (IUL) is a wholly owned knowledge and technology venturing company of Ulster University. Investment funds are provided by IUL for the commercial development of Ulster's research, to ensure the diffusion of knowledge into the private sector and promote the industry attractiveness of its Intellectual Property.IUL Investment Policy goals are to:- create an entrepreneurial environment in the University that encourages and rewards the generation of new inventions and knowledge, including educational materials, by staff and students- facilitate the transfer of new commercially and socially important inventions and knowledge to society- maximise the University's commercial impactIUL aims to maximise the commercial and economic impact of Ulster's research, and achieve a long-term rate of return that in real terms shall equal or exceed the rate of spending on its investments, and to do so with an acceptable level of risk.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Innovation Ulster invests in
Stages Innovation Ulster invests in
Countries Innovation Ulster invests in
Round sizes
Round size
- Seed
- $106k–$781k
- Series A
- $3.1M–$4.3M
Investment Focus
Industry
- Health Care 4 (27%)
- Biotechnology 2 (13%)
- iOS 1 (7%)
- Sports 1 (7%)
- Medical 1 (7%)
Stage
- Seed 5 (33%)
- Series A 2 (13%)
- Funding Round 2 (13%)
- Pre-Seed 1 (7%)
- Venture - Series Unknown 1 (7%)
Country
- United Kingdom 7 (47%)
- Ireland 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| PulseAI is an medical technology startup that uses AI to detection heart disease. | Seed / Jan 12, 2026 | ||
| Ilimex designs air purification and sterilisation units. | $781.3K / Seed / Nov 04, 2025 | ||
| Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research anddevelopment activities aimed at improving the competitiveness of the business. | $6.7M / Venture - Series Unknown / Aug 19, 2025 | ||
| RETìníZE is an AR, VR, multi-screen installations, and software development. | $1.6M / Feb 25, 2025 | ||
| 3D printing is revolutionizing healthcare and Axial3D is at the forefront of this innovation with a vision to make 3D printing a part of mainstream medical practice. They create precise, patient-specific 3D printed models generated directly from patient CT and MRI scan data. 3D printed models facilitate a better understanding of abnormalities,encourage novel surgical techniques and improve the surgical outcome for patients. Providing a unique Online Ordering Portal to securely upload scans in minutes, their expert team use the latest 3D printing technology to create precise physical 3D printed models of your patient’s anatomy and deliver directly to the consultant. | $18.2M / Dec 17, 2024 | ||
| 3D printing is revolutionizing healthcare and Axial3D is at the forefront of this innovation with a vision to make 3D printing a part of mainstream medical practice. They create precise, patient-specific 3D printed models generated directly from patient CT and MRI scan data. 3D printed models facilitate a better understanding of abnormalities,encourage novel surgical techniques and improve the surgical outcome for patients. Providing a unique Online Ordering Portal to securely upload scans in minutes, their expert team use the latest 3D printing technology to create precise physical 3D printed models of your patient’s anatomy and deliver directly to the consultant. | $3.1M / Series A / Jul 23, 2019 | ||
| Researched for over 15 years NeuroCONCISE offers a wearable neurotechnology which includes hardware and software that non-invasively measures and translates brainwaves into control signals that allow people to communicate and interact with computers without moving. | $105.7K / Seed / Mar 26, 2019 | ||
| An innovative drug delivery company specialising on the design and formulation of topical delivery system for a wide range of medical, cosmetic, and skin care applications. | $4.3M / Series A / May 31, 2018 | ||
| Researched for over 15 years NeuroCONCISE offers a wearable neurotechnology which includes hardware and software that non-invasively measures and translates brainwaves into control signals that allow people to communicate and interact with computers without moving. | $172.9K / Seed / Jan 01, 2017 | ||
| An innovative drug delivery company specialising on the design and formulation of topical delivery system for a wide range of medical, cosmetic, and skin care applications. | $300.7K / Seed / Jun 25, 2015 | ||
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Innovation Ulster invest in?
Innovation Ulster invests primarily in Health Care, Biotechnology and iOS startups, most often at Seed and Series A stage. Most of the 15 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Innovation Ulster invest in?
Innovation Ulster typically joins rounds of $106k–$781k at Seed and $3.1M–$4.3M at Series A. These are whole funding-round sizes, not Innovation Ulster's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Innovation Ulster took part in.
When did Innovation Ulster last invest?
The most recent investment recorded for Innovation Ulster closed in Jan 2026. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
